FdaApplication
NDA 206843
Identifiers
- fda_app_no: NDA206843
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL-MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2015-07-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAKLINZA | DACLATASVIR DIHYDROCHLORIDE | EQ 30MG BASE | TABLET;ORAL |
| DAKLINZA | DACLATASVIR DIHYDROCHLORIDE | EQ 90MG BASE | TABLET;ORAL |
| DAKLINZA | DACLATASVIR DIHYDROCHLORIDE | EQ 60MG BASE | TABLET;ORAL |
3 products